These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 29187298)
1. Regional specificity of matrix metalloproteinase-9 expression in the brain: voxel-level mapping in primary glioblastomas. Fan X; Qi C; Liu X; Wang Y; Liu S; Li S; Wang L; Wang Y Clin Radiol; 2018 Mar; 73(3):283-289. PubMed ID: 29187298 [TBL] [Abstract][Full Text] [Related]
2. Anatomical specificity of vascular endothelial growth factor expression in glioblastomas: a voxel-based mapping analysis. Fan X; Wang Y; Wang K; Liu S; Liu Y; Ma J; Li S; Jiang T Neuroradiology; 2016 Jan; 58(1):69-75. PubMed ID: 26453565 [TBL] [Abstract][Full Text] [Related]
3. Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas. Fan X; Wang Y; Liu Y; Liu X; Zhang C; Wang L; Li S; Ma J; Jiang T J Neurooncol; 2016 Jul; 128(3):455-62. PubMed ID: 27230769 [TBL] [Abstract][Full Text] [Related]
4. Identifying radiographic specificity for phosphatase and tensin homolog and epidermal growth factor receptor changes: a quantitative analysis of glioblastomas. Wang Y; Fan X; Zhang C; Zhang T; Peng X; Qian T; Ma J; Wang L; Li S; Jiang T Neuroradiology; 2014 Dec; 56(12):1113-20. PubMed ID: 25228449 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Munaut C; Noël A; Hougrand O; Foidart JM; Boniver J; Deprez M Int J Cancer; 2003 Oct; 106(6):848-55. PubMed ID: 12918061 [TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging-derived kep as a potential biomarker of matrix metalloproteinase 9 expression in patients with glioblastoma multiforme: a pilot study. Awasthi R; Pandey CM; Sahoo P; Behari S; Kumar V; Kumar S; Misra S; Husain N; Soni P; Rathore RK; Gupta RK J Comput Assist Tomogr; 2012; 36(1):125-30. PubMed ID: 22261782 [TBL] [Abstract][Full Text] [Related]
7. Findings of DTI-p maps in comparison with T Beigi M; Safari M; Ameri A; Moghadam MS; Arbabi A; Tabatabaeefar M; SalighehRad H Cancer Imaging; 2018 Sep; 18(1):33. PubMed ID: 30227891 [TBL] [Abstract][Full Text] [Related]
8. Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas. Zhang T; Wang Y; Fan X; Ma J; Li S; Jiang T; Wang L J Neurol Sci; 2014 Nov; 346(1-2):94-8. PubMed ID: 25130928 [TBL] [Abstract][Full Text] [Related]
9. Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes. Li HY; Sun CR; He M; Yin LC; Du HG; Zhang JM World Neurosurg; 2018 Apr; 112():e407-e414. PubMed ID: 29355809 [TBL] [Abstract][Full Text] [Related]
10. Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas. Liu TT; Achrol AS; Mitchell LA; Du WA; Loya JJ; Rodriguez SA; Feroze A; Westbroek EM; Yeom KW; Stuart JM; Chang SD; Harsh GR; Rubin DL AJNR Am J Neuroradiol; 2016 Apr; 37(4):621-8. PubMed ID: 26744442 [TBL] [Abstract][Full Text] [Related]
11. Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI. Bosnyák E; Kamson DO; Robinette NL; Barger GR; Mittal S; Juhász C J Neurooncol; 2016 Jan; 126(2):317-25. PubMed ID: 26514361 [TBL] [Abstract][Full Text] [Related]
12. Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth. Toh CH; Castillo M AJNR Am J Neuroradiol; 2017 Feb; 38(2):288-293. PubMed ID: 27856439 [TBL] [Abstract][Full Text] [Related]
13. Non-enhancing de novo glioblastoma: report of two cases. Cohen-Gadol AA; DiLuna ML; Bannykh SI; Piepmeier JM; Spencer DD Neurosurg Rev; 2004 Oct; 27(4):281-5. PubMed ID: 15449198 [TBL] [Abstract][Full Text] [Related]
14. Quantification of glioblastoma mass effect by lateral ventricle displacement. Steed TC; Treiber JM; Brandel MG; Patel KS; Dale AM; Carter BS; Chen CC Sci Rep; 2018 Feb; 8(1):2827. PubMed ID: 29434275 [TBL] [Abstract][Full Text] [Related]
15. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor. Toyonaga T; Yamaguchi S; Hirata K; Kobayashi K; Manabe O; Watanabe S; Terasaka S; Kobayashi H; Hattori N; Shiga T; Kuge Y; Tanaka S; Ito YM; Tamaki N Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):611-619. PubMed ID: 27752745 [TBL] [Abstract][Full Text] [Related]
16. Segmentation of peritumoral oedema offers a valuable radiological feature of cerebral metastasis. Zhou C; Yang Z; Yao Z; Yin B; Pan J; Yu Y; Zhu W; Hua W; Mao Y Br J Radiol; 2016 Jul; 89(1063):20151054. PubMed ID: 27119727 [TBL] [Abstract][Full Text] [Related]
17. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066 [TBL] [Abstract][Full Text] [Related]
18. In vivo MR imaging of folate-receptor expression with the folate-specific nanospheres in a C6 glioblastoma model. An Y; Tang Q; Yang R; Liu D; Zhang D Comput Assist Surg (Abingdon); 2017 Dec; 22(sup1):312-318. PubMed ID: 29103327 [TBL] [Abstract][Full Text] [Related]
19. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Fayed N; Dávila J; Medrano J; Olmos S Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889 [TBL] [Abstract][Full Text] [Related]
20. Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors. Tews DS; Nissen A Invasion Metastasis; 1998-1999; 18(5-6):271-84. PubMed ID: 10729772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]